NCLAT Lets Adani's JAL Deal Proceed, Vedanta Appeal Adds Risk

LAWCOURT
Whalesbook Logo
AuthorAarav Shah|Published at:
NCLAT Lets Adani's JAL Deal Proceed, Vedanta Appeal Adds Risk
Overview

The National Company Law Appellate Tribunal (NCLAT) has allowed Adani Enterprises' acquisition plan for Jaiprakash Associates (JAL) to proceed. However, the tribunal stated implementation depends on Vedanta Limited's pending appeal, leaving the multi-billion dollar deal's final outcome uncertain. The NCLAT will hear Vedanta's challenge, continuing legal scrutiny over the distressed firm's assets.

Tribunal Allows Adani's Plan to Advance
The appellate tribunal's decision to permit Adani Enterprises' resolution plan for Jaiprakash Associates (JAL) to move forward, albeit conditionally, now directs attention to the prolonged legal battles that will determine the acquisition's ultimate success and valuation.

Conditional Approval and Stock Moves
On Tuesday, the NCLAT rejected Vedanta Limited's request for an immediate halt to Adani Enterprises' approved resolution plan for JAL. The tribunal specified that Adani's plan can only be put into action after Vedanta's appeal is decided. This means Adani's progress is provisional, with potential future reversals pending a full legal review. Adani Enterprises' stock rose 3.08% to ₹1864.75 on March 25, 2026, possibly reacting to the removal of an immediate obstacle. Vedanta's shares, however, fell 4.11% to ₹644.60 on March 23, 2026, likely due to investor caution over the continued legal complexities.

Financial Details and Deal Context
Adani Enterprises, valued at about ₹2.22 trillion as of March 22, 2026, has been actively acquiring distressed assets through India's insolvency process. Its Price-to-Earnings (P/E) ratio was 66.33 on March 25, 2026, suggesting high growth expectations. Adani's approved plan for JAL is worth around ₹14,535 crore. Vedanta Limited, with a market value of ₹2.52 trillion as of March 24, 2026 (and a P/E of 12.70 on March 21, 2026), had also sought to acquire JAL, reportedly offering ₹17,000 crore in September 2025. Vedanta's challenge argues that the Committee of Creditors (CoC) overlooked procedural issues and failed to maximize value, despite Adani's plan being approved by 93.81% of votes in November 2025. The acquisition of JAL, which faces claims over ₹57,000 crore and owes ₹55,357.39 crore in borrowings as of February 28, 2026, is a complex task, especially given growth in India's infrastructure sector.

Vedanta's Grounds for Appeal
Vedanta's appeal introduces significant risk to Adani's acquisition plan. Vedanta claims the CoC wrongly rejected its supplementary bid addendum, which it said clarified terms to boost creditor returns. The CoC, however, cited bidding rules prohibiting such addendums. This conflict between process fairness and potential value could result in lengthy legal battles, a common issue in India's insolvency cases, potentially changing the deal's final conditions. CreditSights previously viewed Vedanta's potential JAL acquisition negatively due to weak strategic links and JAL's high debt. Questions may also arise regarding Adani's own debt levels given its active pursuit of distressed assets. Although the NCLAT didn't issue an immediate stay, Adani's control over JAL's significant real estate, cement, and power assets remains uncertain pending the full hearing.

Upcoming Hearing and Deal Uncertainty
The NCLAT's upcoming hearing on Vedanta's appeal will be crucial for the JAL acquisition's future. The decision could confirm Adani's control, possibly with minor legal changes, or lead to renegotiations or even a reversal of the initial approval. This situation highlights the high-stakes environment of India's distressed asset market, where legal tactics heavily influence strategic moves and valuations for companies like Adani Enterprises and Vedanta.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.